EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
84 hedge funds and large institutions have $191M invested in Eiger BioPharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
13% less capital invested
Capital invested by funds: $220M → $191M (-$28.2M)
Holders
84
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$2.83M | |
| 2 | +$2.15M | |
| 3 | +$1.39M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.34M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$1.28M |
Top Sellers
| 1 | -$19M | |
| 2 | -$4.71M | |
| 3 | -$2.96M | |
| 4 |
TI
Telemetry Investments
New York
|
-$1.63M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.56M |